Related Experiment Video
Updated: May 7, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC)
Wu Yungang1, Li Xiaoyu2, Taizhong Pang2
1Department of Otolaryngology-Head and Neck Surgery, Qi-Lu Hospital, Shandong University, Jinan, Shandong Province, PR China; Department of Otolaryngology-Head and Neck Surgery, the Affiliated Hospital of Jining Medical University, Jining, Shandong Province, PR China.
Abstract:
microRNAs, a family of small non-coding RNAs, involve in the pathogenesis of several types of cancers, including laryngeal squamous cell carcinoma (LSCC). MiR-370 is frequently aberrant expressed in various types of human cancer including LSCC. However, the role for miR-370 in LSCC remains elusive. Here, we demonstrate that miR-370 was down-regulated in human LSCC tissues. Furthermore, there was an inverse relationship between Forkhead Box ml (FoxM1), which was up-regulated and miR-370 expression in LSCC tissues. FoxM1 was subsequently predicted by bioinformatics and verified to be a target of miR-370 by Luciferase reporter assay. Restored expression of miR-370 in Hep2 cells significantly inhibited cell proliferation. In conclusion, our results suggest that miR-370 may function as a tumor suppressor in LSCC through downregulation of FoxM1, suggesting that miR-370 could serve as a novel potential maker for LSCC therapy.
Insights
MicroRNA-370 (miR-370) is down-regulated in laryngeal squamous cell carcinoma (LSCC). Restoring miR-370 inhibits LSCC cell proliferation by targeting Forkhead Box M1 (FoxM1), suggesting its tumor suppressor role.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs regulate gene expression and are implicated in various cancers.
- Laryngeal squamous cell carcinoma (LSCC) pathogenesis involves aberrant microRNA expression.
- The specific role of miR-370 in LSCC has not been fully elucidated.
Purpose of the Study:
- To investigate the expression and function of miR-370 in laryngeal squamous cell carcinoma.
- To identify potential targets of miR-370 within LSCC.
- To evaluate the therapeutic potential of miR-370 in LSCC.
Main Methods:
- Quantitative analysis of miR-370 expression in LSCC tissues.
- Bioinformatic prediction and luciferase reporter assays to validate miR-370 targets.
- Cell proliferation assays in LSCC cell lines (Hep2) following miR-370 restoration.
Main Results:
- miR-370 expression was significantly down-regulated in human LSCC tissues.
- An inverse correlation was observed between miR-370 and Forkhead Box M1 (FoxM1) expression in LSCC.
- FoxM1 was confirmed as a direct target of miR-370.
- Restoration of miR-370 suppressed proliferation in Hep2 LSCC cells.
Conclusions:
- miR-370 acts as a tumor suppressor in LSCC by down-regulating FoxM1.
- miR-370 holds potential as a diagnostic marker and therapeutic target for LSCC.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...